About us

We develop and manufacture biosimilars, partnering with biotechnology companies around the planet, to improve patient access to much needed therapies.

We create quality biosimilars with passion from our three sites in Poland and the Netherlands, these are some of the most modern and largest facilities in Europe.

Our history

Our values

These are the values that we at Polpharma Biologics are guided by, help shape our decisions and drive us forward. We care about:

Creating quality biologics with passion

  • We are passionate about providing safe and effective medicines to patients.
  • We work with dedication and find innovative solutions.
  • We are committed to positive outcomes and delivering projects on time, to specification.

Delivering on our commitments

  • We are self-motivated to reach the end result - “wait and see” is not in our vocabulary.
  • We are experts in managing projects and communicate clearly and concisely.
  • We anticipate potential issues before they arise, always ensuring high quality outcomes.

Being respectful and transparent

  • We are open and honest without exception.
  • We value everyone equally and always treat others with respect.
  • We like to collaborate and can rely on each other.

Our sites

With state-of-the-art facilities across Europe, Polpharma Biologics is at the forefront of the next wave in biotechnology, leveraging our knowledge, capabilities and footprint to develop innovative solutions for the industry.

icon Gdańsk

Our Gdansk site includes mammalian and microbial R&D and manufacturing facilities for mid-scale production including drug product and fill finish.

icon Warsaw

Our Warsaw site is one of the largest biologics manufacturing sites in Europe, with capabilities for preclinical, clinical and commercial supply to EU and US standards.

icon Utrecht

Our Utrecht site is one of innovation and leads the discovery, optimization and development of novel biologics and biosimilars as well as being home to our industry leading cell line development platform.

Our sites

With state-of-the-art facilities across Europe, Polpharma Biologics is at the forefront of the next wave in biotechnology, leveraging our knowledge, capabilities and footprint to develop innovative solutions for the industry.

  • Gdańsk
  • Warsaw - Duchnice
  • Utrecht
  • Our Gdansk site includes mammalian and microbial R&D and manufacturing facilities for mid-scale production including drug product and fill finish.

  • Our Warsaw site is one of the largest biologics manufacturing sites in Europe, with capabilities for preclinical, clinical and commercial supply to EU and US standards.

  • Our Utrecht site is one of innovation and leads the discovery, optimization and development of novel biologics and biosimilars as well as being home to our industry leading cell line development platform.

Innovation in Poland

Over the last decade Polpharma Biologics has created a biotechnology sector almost from scratch in Poland. We consistently invest, not only laboratories and production lines, but also in know-how, driving growth of highly-qualified jobs, as well as developing cooperation between science and business.

Our team

At Polpharma Biologics, our commitment to excellence begins at the top. With decades of combined experience in the development, manufacture and commercialization of biopharmaceuticals. Our international management team brings both knowledge and passion to every project.

"It is here that new molecules, active substances and drugs for the largest companies in the world are created"

Next
Jerzy Starak

Founder and Owner, Polpharma Biologics Group

“We care about delivering on our commitments”

Next
Hannes Teissl

Vice Chairman, Polpharma Biologics Group

“We are passionate about getting safe and effective medicines to patients”

Next
Dr Joerg Windisch

President & CEO, Polpharma Biologics Group

"We care about delivering on our commitments"

Next
Piotr Korycki

President, Polpharma Biologics Gdańsk & Managing Director, Polpharma Biologics Group

“We work with dedication and find innovative solutions”

Next
Frederic Papp

President, Polpharma Biologics Warsaw

Let’s collaborate and deliver quality biosimilars together.

Get in touch for more information.